Chemed Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CXM.F | NHC | HCSG | CVSG.L | THC | CRRX.TO | |
|---|---|---|---|---|---|---|
| Market cap | 6.25B | 3.33B | 1.79B | 940.78M | 23.26B | 215.66M |
| P/E (TTM) | 26.8 | 23.9 | 17.9 | 58.8 | 8.5 | 8.3 |
| Forward P/E | 25.0 | 494.0 | 21.2 | 13.6 | 14.3 | 11.3 |
| Price/book | 8.1 | 3.0 | 3.4 | 3.4 | 4.3 | 2.0 |
| Dividend yield | 0.50% | 1.26% | — | 0.65% | — | 2.59% |
| 1-year change | +24.34% | +69.92% | +51.83% | +11.14% | +27.84% | −8.20% |
| Today | +2.55% | +3.19% | +3.79% | +2.29% | +9.58% | +1.19% |
The closest companies by business and industry (Medical Care Facilities). Prices may be delayed up to 15 min.
Latest news
All CXM.F news ›Rhythm Pharmaceuticals changes its tune with LG Chem on obesity drug
Rhythm Pharmaceuticals has amended its exclusive license agreement with LG Chem for bivamelagon, an oral small-molecule melanocortin-4 receptor (MC4R) agonist. The changes raise the deal's potential value from $305 million to as much as…
Natura Hue-Chem Open Offer Seeks 26% Stake at ₹42 a Share
Natura Hue-Chem Limited has received an open offer from Kanika Chahal and Anuj Chahal to acquire up to 10,77,778 shares, or 26% of voting equity, at ₹42 per share after the acquirers agreed to buy 6,43,600 shares from existing promoters on…
LG Chem Expands Rare Obesity Drug Deal to 1.15 Trillion Won
LG Chem expanded its bivamelagon licensing deal with Rhythm Pharmaceuticals to 1.15 trillion won, with record upfront payments of about 600 billion won. LG Chem (051910) has expanded the value of its licensing deal with U.S.-based Rhythm…
LG Chem Raises Bivamelagon Deal Value with U.S.-Based Rhythm
LG Chem announced on Nov. 3 (on Oct. 2, local time) that it agreed to amend the technology export contract regarding the global development and sales of ‘Vivamelagon’, an oral melanocortin-4 receptor (MC4R) agonist, with Rhythm…
Chemed (CHE) versus Its Competitors Head-To-Head Review
Posted by Danessa Lincoln on Nov 3rd, 2026 Chemed (NYSE:CHE – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its peers? We will compare Chemed to related…
LG Chem Expands Obesity Drug Licensing Deal to $855 Million
Deal Value Grows From $305 Million to $855 Million Company to Receive $350 Million in Additional Upfront Payments Through 2029 Positive Phase 2 Results Clear Path to Phase 3 This Year LG Chem (051910.KS) has expanded the global licensing…
LG Chem boosts Rhythm deal as obesity drug advances toward global phase 3
Rhythm, not LG Chem, will shoulder bigger upfronts as Bivamelagon readies for phase 3 and milestones climb LG Chem(051910) expanded the size of the contract for a rare obesity treatment candidate it out-licensed to Rhythm Pharmaceuticals…
LYB looks to EU for chem recycling growth
LyondellBasell now expects to build its second chemical recycling plant, MoreTec-2, in Europe rather than the US, because of insufficient US regulatory support, executives said during the company’s third-quarter earnings call. The…
Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
-- Amendment revised royalty structure from low-to-mid-single digits to 1% on global net sales of Rhythm MC4R agonists, including setmelanotide, bivamelagon and RM-718 -- -- Rhythm to pay LG Chem additional fixed payments totaling $350…
Chemed: Georgia Inspectors Placed VITAS’s State Operation in ‘Immediate Jeopardy’ After Patients in Crisis Experienced Lengthy Wait Times; Managers Told Inspectors They Were Unaware of State’s One-Hour Response Rule
Chemed: Georgia Inspectors Placed VITAS's State Operation in ‘Immediate Jeopardy’ After Patients in Crisis Experienced Lengthy Wait Times; Managers Told Inspectors They Were Unaware of State's One-Hour Response Rule The Capitol Forum…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- pragativadi.com6
- newsable.asianetnews.com5
- univest.in5
- en.sedaily.com4
- fxleaders.com4
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 98 articles, not a forecast.